Ilex Medical Ltd
TASE:ILX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5 780
7 520
|
| Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IL |
I
|
Ilex Medical Ltd
TASE:ILX
|
714.3m ILS |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
102.5B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.8B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
67.7B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.3B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.3B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.6B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.4B HKD |
Loading...
|
Market Distribution
| Min | -85 210% |
| 30th Percentile | -8.6% |
| Median | 1.8% |
| 70th Percentile | 7.2% |
| Max | 23 652.1% |
Other Profitability Ratios
Ilex Medical Ltd
Glance View
Ilex Medical Ltd. engages in medical diagnostics field. The company is a supplier of in vitro diagnostic equipment and laboratory management software. The firm offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Company’s subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Ilex Medical Ltd is 4.8%, which is below its 3-year median of 6.3%.
Over the last 3 years, Ilex Medical Ltd’s Net Margin has decreased from 11.9% to 4.8%. During this period, it reached a low of 3.7% on Mar 31, 2025 and a high of 11.9% on Sep 30, 2022.